Julian and Katharina recently published a new paper, where 89 patients were investigated for changes between the groups with and without previous open-label placebo treatment regarding pain intensity (primary outcome), disability and mood (secondary outcomes), biopsychosocial factors and lifestyle (exploratory outcomes) from parent baseline to follow-up. The results: Over the three-year period, there were no differences in any outcome between groups with and without open-label placebo treatment. Therefore, the study does not support the previously suggested assumption that a three-week open-label placebo treatment has long-term effects. Read the full article here.